Oct
2026
Fiera Milano, Italy
Visit us
stand 12F58, Contract Manufacturing & Services

Thousand Oaks Biologics Inc

Exhibitor at CPHI Milan 2026
About Us

Thousand Oaks Biologics Inc. (TOBio) is a leading Integrated CMC Solution Provider, specializing in comprehensive solutions for large-scale, compliant biopharmaceutical production. Its business spans three key segments: Biopharmaceutical CDMO, Cell Culture Medium, and Early-Stage Research Services. These products and technical services are widely applied in the production of recombinant proteins, antibody-based drugs, human and veterinary vaccines, and cell therapy products.In the CDMO segment, TOBio delivers end-to-end CMC solutions through its GMP bases in Shanghai and Nantong, cat...

Read more Show less
Products
Show more Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • Country/Region:
    China
  • On CPHI since:
    2024
  • Certificates:
    4
  • Employees:
    500 - 999
Company types
Biopharmaceutical company
CMO/CDMO
Contract Service
Drug delivery device Supplier/Manufacturer
Pharmaceutical company
Primary activities
Analytical Services
Biopharmaceutical
Contract Manufacturer
Intermediates Manufacturer
Pharmaceutical Company (innovator finished products)
Supply Chain
Technology
View company profile
Contact info
Show contact info Hide contact info
Event information
CPHI Milan 2026
  • 6 Oct 2026 - 8 Oct 2026
  • Fiera Milano, Italy
  • Visit us at stand 12F58, Contract Manufacturing & Services

Products Featured at CPHI Milan 2026

  • Cell Culture Media

    Product Cell Culture Media

    JSBio, a prominent brand in Asia, is a leading provider of serum-free cell culture media. Our comprehensive product portfolio covers a wide spectrum of cell lines, with a strong focus on mainstream ones like CHO, 293, insect cells, and BHK .These media are extensively applied across core biopharmaceutical ...
  • Shun Luo

    Product Shun Luo

  • CDMO Services

    Product CDMO Services

    Thousand Oaks Biopharmaceutical (TOBio), as a CDMO specializing in the large molecule sector, offers an integrated suite of CMC solutions from candidate molecules through clinical and commercial manufacturing. Operating with the philosophy of an "innovator's drug development perspective," the core technica...
  • Early-stage Drug Discovery

    Product Early-stage Drug Discovery

    An early research services subsidiary of Thousand Oaks Biologics offers molecular design and optimization, linker-payload and antibody screening, pharmacological efficacy and drug evaluation, and other services. Collaborates with clients on demand to develop differentiated innovative molecules and licenses...

Thousand Oaks Biologics Inc Resources (1)